Waters Co. (NYSE:WAT) Shares Sold by Neuberger Berman Group LLC

Neuberger Berman Group LLC reduced its position in Waters Co. (NYSE:WAT) by 5.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,479 shares of the medical instruments supplier’s stock after selling 79 shares during the period. Neuberger Berman Group LLC’s holdings in Waters were worth $427,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bailard Inc. lifted its stake in shares of Waters by 1.2% in the 2nd quarter. Bailard Inc. now owns 2,034 shares of the medical instruments supplier’s stock valued at $703,000 after purchasing an additional 25 shares in the last quarter. Savant Capital LLC lifted its position in Waters by 2.4% during the 2nd quarter. Savant Capital LLC now owns 1,296 shares of the medical instruments supplier’s stock worth $448,000 after acquiring an additional 30 shares in the last quarter. IndexIQ Advisors LLC lifted its position in Waters by 3.0% during the 2nd quarter. IndexIQ Advisors LLC now owns 1,020 shares of the medical instruments supplier’s stock worth $353,000 after acquiring an additional 30 shares in the last quarter. Eqis Capital Management Inc. lifted its position in Waters by 1.0% during the 2nd quarter. Eqis Capital Management Inc. now owns 3,265 shares of the medical instruments supplier’s stock worth $1,128,000 after acquiring an additional 31 shares in the last quarter. Finally, Berman Capital Advisors LLC lifted its position in Waters by 24.3% during the 2nd quarter. Berman Capital Advisors LLC now owns 179 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 35 shares in the last quarter. 88.08% of the stock is currently owned by institutional investors and hedge funds.

Shares of NYSE WAT opened at $361.17 on Thursday. Waters Co. has a twelve month low of $212.85 and a twelve month high of $428.22. The company has a current ratio of 2.41, a quick ratio of 1.89 and a debt-to-equity ratio of 5.98. The company has a market capitalization of $22.16 billion, a price-to-earnings ratio of 34.14, a price-to-earnings-growth ratio of 4.20 and a beta of 0.80. The business has a 50 day simple moving average of $389.25 and a 200-day simple moving average of $354.41.

Waters (NYSE:WAT) last issued its quarterly earnings results on Tuesday, August 3rd. The medical instruments supplier reported $2.60 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.29 by $0.31. Waters had a return on equity of 387.10% and a net margin of 24.73%. The business had revenue of $681.70 million during the quarter, compared to the consensus estimate of $625.36 million. During the same period in the previous year, the business earned $2.10 EPS. The business’s quarterly revenue was up 31.1% on a year-over-year basis. As a group, equities analysts predict that Waters Co. will post 10.66 earnings per share for the current year.

In other Waters news, Director Thomas P. Salice sold 5,000 shares of the business’s stock in a transaction on Thursday, August 5th. The stock was sold at an average price of $395.00, for a total transaction of $1,975,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Christopher A. Kuebler sold 3,000 shares of the business’s stock in a transaction on Wednesday, August 18th. The stock was sold at an average price of $405.62, for a total value of $1,216,860.00. Following the transaction, the director now owns 13,763 shares of the company’s stock, valued at approximately $5,582,548.06. The disclosure for this sale can be found here. Insiders sold a total of 13,260 shares of company stock valued at $5,300,907 over the last quarter. Company insiders own 1.10% of the company’s stock.

Several equities analysts recently commented on the company. Evercore ISI raised Waters from an “in-line” rating to an “outperform” rating and set a $400.00 price target on the stock in a research report on Tuesday, July 6th. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $418.00 price target on the stock in a research report on Saturday, August 7th. Robert W. Baird lifted their price objective on Waters from $297.00 to $360.00 and gave the stock a “neutral” rating in a report on Wednesday, August 4th. SVB Leerink lifted their price objective on Waters from $370.00 to $385.00 and gave the stock a “market perform” rating in a report on Wednesday, August 4th. Finally, Citigroup lifted their price objective on Waters from $315.00 to $400.00 and gave the stock a “neutral” rating in a report on Wednesday, August 4th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $306.64.

Waters Profile

Waters Corp. is a specialty measurement company which engages in analytical workflow solutions involving liquid chromatography, mass spectrometry and thermal analysis innovations. It operates through the Waters and TA segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and related services.

Read More: What are the FAANG Stocks?

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.